Articles On Imugene (ASX:IMU)

Optimism about China reopening and hopes for a slowdown in interest rate hikes fuelled the share market’s best week in two months. The S&P/ASX 200 climbed 48 points or 0.66 per cent today to extend its tally for the week to almost 3....

The ASX has had a big first two weeks, rising by over 4% Investors are bullish as inflation looks to have peaked in the US and Europe Earnings season will be next test for the markets   The ASX 200 rose another 0.70% higher on Friday, ext...

A seventh rise in eight sessions powered the share market to its highest in more than a month after Wall Street welcomed further evidence of inflation cooling. The S&P/ASX 200 rallied 63 points or 0.87 per cent to 7344. A strong star...

There was likely a spring in the step of S&P/ASX 200 Index (ASX: XJO) investors today as the market jumped higher. The index closed Thursday’s session 1.18% higher at 7,280.4 points. It followed a joyous session on Wall Street overni...

The ASX surged by another 1% on Thursday The all crucial US CPI will be released later today (US time) ASX lithium stocks rallied   The ASX 200 rallied by yet another 1% on Thursday, closely tracking the bullish sentiment on Wall Street o...

Record retail sales helped the share market brush off the prospect of further interest rate hikes this year after inflation rebounded more than expected. The S&P/ASX 200 climbed 69 points or 0.96 per cent towards its fifth gain in si...

The ASX down by 0.30% on Tuesday Iron ore miners pare gains as China clamps down on speculation Jerome Powell will speak tonight   The ASX 200 lost 0.30% on Tuesday as the biggest three sectors – Energy, Mining and Financial – took a tumb...

ShareCafeAlmost all sectors lower despite signs of optimism in the US: ASX down 0.3% at noon by Peter Milios   Overnight Chris Zaccarelli, Chief Investing Officer at the Independent Advisor Alliance, stated, “Today is another one of those d...

Market goes out too hard, too early and beds down for a lengthy afternoon snooze Tempus Resources still riding high after drilling into phenomenally good gold grades Betting is now open on how long until the ASX’s next “how to announce stu...

The ASX rose in a broad brushed rally Fortescue’s CFO of 13 years quit Australian and US CPI will be due for release later this week   The ASX extended gains in a broad brushed rally on Monday, with 9 out of 11 sectors finishing in the gr...

The share market sealed its longest win run since early November with a fourth straight rise following strong gains on Wall Street as buyers bet on a soft landing for the US economy. The S&P/ASX 200 trimmed its advance as iron ore pr...

Highlights Imugene Limited (ASX:IMU) marked 2022 with breakthrough developments in its clinical studies, progressing to build a deep clinical pipeline At present, IMU has five ongoing clinical trials. However, a total of nine clinical...

Imugene has now crossed ethics approval off is list, and the way is now clear for clinical trials to begin in Australia. The post Imugene Gains Ethics Approval and Receives 5% Share Bump appeared first on Money Morning Australia.

Aussie shares hit a three-week high amid optimism about cooling inflation and China reopening. The S&P/ASX 200 rallied 44 points or 0.62 per cent by mid-session. The advance put the Australian benchmark on track for a fourth straight...

LBT Innovati0ns engaged by global pharma company, AstraZeneca Volpara nabs $7m plus contracts Imugene receives ethics approval for Vaxinia   LBT to partner with AstraZeneca LBT Innovations (ASX:LBT) surged 22%% this morning after announci...

Highlights Imugene Limited (ASX:IMU) has received human research ethics approval for Phase I human trial of anti-cancer oncolytic virotherapy VAXINIA Tasman Oncology Research, a comprehensive cancer hospital in South Australia, is the...

Imugene (IMU) receives Human Research Ethics Committee (HREC) approval to commence a phase one clinical trial of its VAXINIA drug in Australia The approval confirms the company has completed all necessary pre-clinical safety and efficacy...

Miners lead shares higher; IGO-Tiangi to buy Essential Metals; Ian Wells to leave Fortescue; Core Lithium relocates; Collimate sale delayed and Imugene gets Vaxinia ethics nod.

The S&P/ASX 200 Index (ASX: XJO) wobbled in and out of the green this afternoon before ultimately closing the day higher. The index was up 0.06% at 7,063.6 points at the end of Thursday’s session. While many miners came in among the...

An early rally lost momentum following soft Chinese economic data and as negative US futures suggested investors were having second thoughts about a hawkish interest rate outlook from the Federal Reserve. The S&P/ASX 200 finished fou...

Australian stocks climbed to their highest in a week after Wall Street took in its stride confirmation interest rates are unlikely to fall this year. The S&P/ASX 200 rose as much as 40 points in early action before resetting to neutr...

The S&P/ASX 200 Index (ASX: XJO) recovered from Tuesday’s fall today, lifting 1.63% to close at 7,059.2 points. Its gains came despite a rough night’s trade on Wall Street. The Dow Jones Industrial Average Index (DJX: .DJI) traded...

Aussie shares climbed into positive territory for 2023 after reports of fresh support for China’s ailing economy helped the market reverse opening-day losses.   Banks, tech companies and gold miners led as the S&P/ASX 200 rallied 113...

The share market bounced off an eight-week low after Wall Street pared sharp initial losses during the US’s first session of 2023.   The S&P/ASX 200 climbed 90 points or 1.3 per cent towards its first gain of the year. The Australian...

Ending the year on a high note, the S&P/ASX 200 Index (ASX: XJO) rallied on the last trading day of 2022. The benchmark index climbed 0.26% to 7,038.7 points, following in the footsteps of the US stock market last night. Nearly all se...

Highlights The ASX 200 benchmark index closed in the green today (December 30), gaining 34.80 points or 0.50% to end at 7,054.90. The index lost 0.74% in the last five days and 6.10% over the last 52 weeks. IT sector emerged as the bi...

Aussie shares fell for a third session, pacing broad falls on Wall Street as markets priced in the risk of a US recession in 2023. The S&P/ASX 200 declined 82 points or 1.16 per cent by the halfway mark. The fall put the index on tra...

A whopping insider buy just went down with shares in technology-focused listed investment company (LIC) Thorney Technologies Ltd (ASX: TEK). Perhaps more excitingly, the purchase was made by a rich lister who boasts a billion-dollar fortun...

It can take a long time to bring a new drug to market, but companies that succeed reap mighty rewards. Any time a company is working in drug manufacturing and clinical research, the compound needs to be tested on human subjects to ensure...

The S&P/ASX 200 falls on first day of Christmas trading week, down 0.21% Nickel Industries (ASX:NIC), gold miners lead ASX large caps gainers Star Entertainment Group tumbles as CEO hits back at increases to casino tax in NSW   ‘Twas...

Highlights The ASX 200 benchmark index closed in the red today (December 19), losing 14.70 points or 0.21% to end at 7,134.00 points. Over the last five days, the index has lost 0.65% and 2.33% over the last 52 weeks. Materials was th...

Australian shares tracked falls on Wall Street after the Federal Reserve raised US interest rates and signalled more hikes next year. The S&P/ASX 200 declined 32 points or 0.44 per cent by mid-session. The market took in its stride u...

Local shares finished higher ahead of the Fed rates call tonight Energy and gold stocks led Binance sees massive withdrawals   Local shares joined Wall Street in the green, up by 0.60%, as traders await the Fed’s rates decision later toni...

The S&P/ASX 200 Index (ASX: XJO) traded in the green on Tuesday, recovering some of yesterday’s slump. At the end of today’s session, the index was 0.31% higher at 7,203.3 points Tech shares were among the market’s best performe...

The share market rose for only the second time in six sessions before halving its gains ahead of risk events in the US.   The S&P/ASX 200 slashed a 47-point opening rally to 22.5 points or 0.31 per cent by the close. Caution set in a...

Local shares finished slightly higher ahead of the FOMC meeting later tonight Sam Bankman-Fried arrested in the Bahamas CSL has a new CEO   Local shares dipped in the afternoon, finishing the day just 0.30% higher despite a strong start....

The S&P/ASX 200 Index (ASX: XJO) had another shocker today, notching up its third loss in a row for the week. The index finished up at 7,175.5 points, down 0.75% for the day. Since Monday, the ASX 200 has already lost a nasty 2%. These...

Energy stocks dragged ASX lower Core Lithium got a Sell rating from Goldman Sachs RBA says it’s still looking into a Central Bank Digital Currency (CBDC) in Australia   Energy stocks dragged local shares lower on Thursday as more talks of...

In morning trade, the Santos Ltd (ASX: STO) share price is edging lower. At the time of writing, the energy producer’s shares are down 0.7% to $7.20. While disappointing, this compares favourably to other energy shares which are falling he...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week with a gain. The benchmark index rose 0.3% to 7,325.6 points. Will the market be able to build on this on Tuesday? Here are five things to watch: ASX 200 expected to fall T...

The S&P/ASX 200 Index (ASX: XJO) got off to a good start this week. The index finished Monday’s session 0.33% higher at 7,325.6 points. The S&P/ASX 200 Energy Index (ASX: XEJ) posted the market’s biggest gains today, lifting 1....

The BHP Group Ltd (ASX: BHP) share price has charged higher today. BHP shares are up 2.80% near the close, trading at $47.00 after hitting a high of $47.25 earlier this afternoon. The S&P/ASX 200 Index (ASX: XJO) is also in the gree...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a solid gain. At the time of writing, the benchmark index is up 0.5% to 7,340.4 points. Four ASX shares that are climbing more than most today a...

NSB files new patent in Australia Imugene doses first patient in Phase 1 trial Cronos and MGC Pharma give sales update   NSB announces patent filing in Australia NeuroScientific Biopharma (ASX:NSB) announced a new patent filing in Austral...

Highlights Australian shares opened flat on Wednesday. The ASX 200 rose marginally in opening trade, up 3.20 points, or 0.044%, to 7,256.50. On Tuesday, the benchmark index ended 0.3% higher at 7,253.3 points. Australi...

The S&P/ASX 200 Index (ASX: XJO) spent the afternoon in the green on Tuesday. The index closed today’s session 0.33% higher at 7,253.3 points. That was despite an early downturn that saw it dump as much as 0.39% to an intraday low of...

The ASX snapped a 4-day winning streak Energy stocks paced the bourse lower The RBA apologised over guidance   Energy paced the ASX lower on Monday as crude prices fell to the lowest level since December last year. At the close, the ASX 2...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

The Imugene Limited (ASX: IMU) share price has had a tough run lately. Imugene shares have dropped nearly 12% since market close on 15 November. The company’s share price was flat today and closed the day trading at 19 cents. Let’s ta...

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. Even well into his 90s...